An all-purpose antimalarial drug target

W. Armand Guiguemde; R. Kiplin Guy

doi:10.1016/j.chom.2012.05.008

An all-purpose antimalarial drug target

W. Armand Guiguemde, R. Kiplin Guy

Producción científica: Short survey › revisión exhaustiva

7 Citas (Scopus)

Resumen

The recent re-emphasis on malaria eradication has made developing drugs that block transmission and terminate latent disease critical. Most drugs do not affect the liver stages - an ability that is crucial to the latter goal. Addressing this problem, Hoepfner et al. (2012) uncover the parasite's lysyl-tRNA synthetase as a druggable target.

Idioma original	English
Páginas (desde-hasta)	555-557
Número de páginas	3
Publicación	Cell Host and Microbe
Volumen	11
N.º	6
DOI	https://doi.org/10.1016/j.chom.2012.05.008
Estado	Published - jun 14 2012

ASJC Scopus subject areas

Parasitology
Microbiology
Virology

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

10.1016/j.chom.2012.05.008

Otros archivos y enlaces

Citar esto

@article{16067c490b1b40eb917edd56d019d509,

title = "An all-purpose antimalarial drug target",

abstract = "The recent re-emphasis on malaria eradication has made developing drugs that block transmission and terminate latent disease critical. Most drugs do not affect the liver stages - an ability that is crucial to the latter goal. Addressing this problem, Hoepfner et al. (2012) uncover the parasite's lysyl-tRNA synthetase as a druggable target.",

author = "Guiguemde, \{W. Armand\} and Guy, \{R. Kiplin\}",

year = "2012",

month = jun,

day = "14",

doi = "10.1016/j.chom.2012.05.008",

language = "English",

volume = "11",

pages = "555--557",

number = "6",

}

TY - JOUR

T1 - An all-purpose antimalarial drug target

AU - Guiguemde, W. Armand

AU - Guy, R. Kiplin

PY - 2012/6/14

Y1 - 2012/6/14

N2 - The recent re-emphasis on malaria eradication has made developing drugs that block transmission and terminate latent disease critical. Most drugs do not affect the liver stages - an ability that is crucial to the latter goal. Addressing this problem, Hoepfner et al. (2012) uncover the parasite's lysyl-tRNA synthetase as a druggable target.

AB - The recent re-emphasis on malaria eradication has made developing drugs that block transmission and terminate latent disease critical. Most drugs do not affect the liver stages - an ability that is crucial to the latter goal. Addressing this problem, Hoepfner et al. (2012) uncover the parasite's lysyl-tRNA synthetase as a druggable target.

UR - https://www.scopus.com/pages/publications/84862286411

UR - https://www.scopus.com/inward/citedby.url?scp=84862286411&partnerID=8YFLogxK

U2 - 10.1016/j.chom.2012.05.008

DO - 10.1016/j.chom.2012.05.008

M3 - Short survey

C2 - 22704614

AN - SCOPUS:84862286411

SN - 1931-3128

VL - 11

SP - 555

EP - 557

JO - Cell Host and Microbe

JF - Cell Host and Microbe

IS - 6

ER -

An all-purpose antimalarial drug target

Resumen

ASJC Scopus subject areas

ODS de las Naciones Unidas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto